CD4 and Alzheimer disease: According to this, blocking of IL-17A in a wild-type mouse model of lung Ad resulted in a decreased number of Foxp3+ Tregs and an increase of IFN-γ and TNF-α producing CD4+ T cells leading to a significant reduction of tumor growth.